Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study

Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study

Methylphenidate (MPH) is the first-line drug for the treatment of children with attention-deficit hyperactivity disorder (ADHD); however, individual curative effects of MPH vary. Many studies have demonstrated that synaptosomal-associated protein 25 (SNAP-25) gene MnlI polymorphisms may be related t...

Full description

Bibliographic Details
Main Authors: Jie Li, Wen-Jie Yan, Yan Wu, Xin-Xin Tian, Yi-Wen Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
functional near-infrared spectroscopy
ADHD
methylphenidate
SNAP-25
polymorphisms
Online Access:https://www.frontiersin.org/articles/10.3389/fnbeh.2021.793643/full

Internet

https://www.frontiersin.org/articles/10.3389/fnbeh.2021.793643/full

Similar Items